The European Commission approved a new dosing regimen for EFrio, enhancing treatment options for Fabry disease patients in the EU. Protalix BioTherapeutics Inc (PLX) received a EUR25 million milestone ...
.info-box .ib-icon { font-size: 1.3rem; flex-shrink: 0; margin-top: 2px; } .info-box p { margin: 0; font-size: 0.92rem; line-height: 1.6; } .info-note { background: # ...
Note this module is made to work with CircuitPython and not MicroPython APIs. Please ensure all dependencies are available on the CircuitPython filesystem. This is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results